Depo Medroxyprogesterone (DMPA) Promotes Papillomavirus Infections but Does Not Accelerate Disease Progression in the Anogenital Tract of a Mouse Model

Depo Medroxyprogesterone (DMPA) Promotes Papillomavirus Infections but Does Not Accelerate Disease Progression in the Anogenital Tract of a Mouse Model

Contraceptives such as Depo-medroxyprogesterone (DMPA) are used by an estimated 34 million women worldwide. DMPA has been associated with increased risk of several viral infections including Herpes simplex virus-2 (HSV-2) and Human immunodeficiency virus (HIV). In the current study, we used the mous...

Full description

Bibliographic Details
Main Authors: Jiafen Hu, Sarah A. Brendle, Jingwei J. Li, Vonn Walter, Nancy M. Cladel, Timothy Cooper, Debra A. Shearer, Karla K. Balogh, Neil D. Christensen
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Viruses
Subjects:
contraceptive
progesterone
Depo-Provera
DMPA
17β-estradiol
lower genital tract
Online Access:https://www.mdpi.com/1999-4915/14/5/980

Internet

https://www.mdpi.com/1999-4915/14/5/980

Similar Items